References
- Melnick A, Licht J D. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93: 3167–3215
- Pandolfi P P, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, et al. Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. Embo J 1992; 11: 1397–1407
- Zayed A, Couban S, Hayne O, Sparavalo N, Shawwa A, Sadek I, Greer W. Acute promyelocytic leukemia: a novel PML/RARα fusion that generates a frameshift in the RARα transcript and ATRA resistance. Leuk Lymphoma 2007; 48(3)489–496
- Salomoni P, Pandolfi P P. The role of PML in tumor suppression. Cell 2002; 108: 165–170
- Bernardi R, Guernah I, Jin D, Grisendi S, Alimonti A, Teruya-Feldstein J, et al. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature 2006; 442: 779–785
- Lin H K, Bergmann S, Pandolfi P P. Cytoplasmic PML function in TGF-beta signalling. Nature 2004; 431: 205–211